Ash Year in Review 2025: Expanding Access and Helping Individuals Get the Care They Deserve

Ash Team
December 23, 2025
5 min read

As 2025 comes to a close, we are taking a moment to reflect on a landmark year defined by a fresh brand identity, strategic growth, and a stubborn dedication to making healthcare inclusive for everyone. At Ash, our core principle remains: when people come first, better health outcomes are possible.

This year, we transitioned from being a leader in at-home health testing to a comprehensive partner in engagement design. By combining population-level insights with personalized approaches, we’ve helped our partners bridge some of the most stubborn care gaps in the industry.

________

A New Look and Strategic Leadership for the Payor Market

We started 2025 with a major brand evolution that represents the future of our organization and its focus on the payor market. While Ash initially established itself through digital health partnerships, our rapidly expanding work with national health plans necessitated a brand renewal that embodies the reliability payors require. This fresh visual identity, featuring our new logo and "droplet", communicates a precision backed by knowledge and a dedication to meeting members where they are.

To accelerate this expansion, we significantly strengthened our leadership and strategic counsel with seasoned executives who bring over 50 years of combined experience:

  • Board of Directors: We welcomed Julie Smith (Chief Growth Officer of tango; formerly of BCBS of Michigan and Anthem Inc.) and Jamie Hall (CEO of CirrusMD) to our board to drive growth across the payor sector.
  • Commercial Leadership: Robyn Dietz joined as Vice President of Growth, bringing deep growth strategy experience from the digital behavioral health space.
  • Product Marketing: Alexis Tilburg was appointed Vice President of Product Marketing, leveraging her extensive background in at-home healthcare to strengthen our market presence.

These investments in talent and identity follow our 2024 Series A financing and the securing of major national health plan contracts. We have leveraged our track record with digital health organizations to build engagement, integration, and reporting tools designed specifically for payor customers to ensure seamless implementation and ongoing value. As our CEO David Stein noted, Ash is now uniquely positioned to help health plans integrate high-impact solutions that enhance member engagement and improve adherence.

High-Impact Solutions for Quality Care

In 2025, we focused heavily on supporting health plans and FEHB carriers in meeting critical HEDIS measures and improving Medicare Star Ratings. We expanded our solution menu to target high-impact areas, including:

  • Colorectal Cancer Screening (COL)
  • Diabetes Management (GSD/HbA1c) 
  • Kidney Health Evaluation (KED)
  • Blood Pressure Control (CBP + BPD)
  • Infectious Disease Screening (HPV, CHL, and STI)

A standout achievement this year was our partnership with a national health plan to reach "non-engagers"—members who historically avoided at-home tests and colonoscopies. By deploying a white-labeled, tech-enabled campaign, we raised FIT kit return rates from 0% to approximately 11% and identified members who had already completed screenings, significantly improving HEDIS reporting accuracy.

Product Innovation: More Than Just a Kit

Our product team stayed sharply focused on reducing patient friction and providing real-time visibility for providers.

The Tasso Device Launch

We integrated the Tasso device, an FDA-cleared, upper-arm blood collection tool that offers a virtually pain-free alternative to traditional finger pricks and dried blood spot cards. This innovation has been critical for:

  • Unlocking testing for New York State populations where DBS cards are restricted.
  • Providing a "premium" experience for telehealth patients.
  • Collecting larger blood samples (500µL) for comprehensive panels like our Complete Metabolic Panel - Lite.

Comprehensive Remote Patient Monitoring (RPM)

Through a strategic partnership with Impilo, we launched an all-in-one solution that pairs clinical-grade at-home lab results with connected monitoring devices. Members can now receive a single branded kit containing both sample collection materials and devices like blood pressure cuffs or glucometers.

Additional Digital Platform Enhancements

We rolled out significant updates to our Client and Patient Portals, including:

  • Real-time data visualizations to monitor program impact as it happens.
  • In-person testing capabilities via our API for multi-modal care needs.

A Year of Recognition and Connection

Ash was honored to receive global recognition this year, appearing on TIME’s World’s Top HealthTech Companies list and Digital Health New York’s (DHNY) 100.

Our team also hit the road to meet the innovators changing the face of healthcare. From hosting events like our ATA NEXUS Happy Hour or watching our CPO Kyle Waters join a talent-packed panel on Democratized Diagnostics at HLTH, we loved meeting and learning alongside so many leaders across the healthcare industry. 

Looking Toward 2026

We’ve grown our team, deepened our technical security expertise, and shipped over one million custom test kits. As we look toward the new year, we remain committed to our mission: deepening health connections and ensuring every individual can take the helm of their own health journey.

Ready to close care gaps in 2026? Contact our team today to see how the Ash platform can scale your custom screening program.

Share this post
Ash Team
December 23, 2025

Other Posts You Might Like

Ash News

Ash Year in Review 2025: Expanding Access and Helping Individuals Get the Care They Deserve

December 23, 2025
Ash News

5 Ash Product Launches in 2025 That Should Be On Your Radar

July 15, 2025
Ash News

Remote Patient Monitoring: Revolutionizing Healthcare with Ash and Impilo

July 11, 2025